ClassID:

92569

C07C217/20 - CPC Classification

Classification description:

Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Recent Application in this class:
#1
20260138955
2026-05-21

METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN

#2
20250347685
2025-11-13

DONOR-ACCEPTOR CONJUGATED OLIGOELECTROLYTES FOR CELL LABELLING AND METHODS THEREOF

#3
20250066286
2025-02-27

COMPOSITIONS OF (Z)-ENDOXIFEN AND METHODS OF ENRICHMENT THEREOF

#4
20240308951
2024-09-19

METHODS FOR THE TREATMENT OF DIABETIC RETINOPATHY AND OTHER OPHTHALMIC DISEASES

#5
20230218549
2023-07-13

Alkoxy compounds for disease treatment

#6
20230183167
2023-06-15

VISIBLE LIGHT ACTIVE BIOMASS DERIVED PHOTOINITIATORS

#7
20220340533
2022-10-27

METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN

#8
20220281803
2022-09-08

MOLECULAR DESIGN OF NEW ANTIBIOTICS AND ANTIBIOTIC ADJUVANTS AGAINST MCR STRAINS

#9
20220054671
2022-02-24

1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof

#10
20210292272
2021-09-23

Salts of Zuclomiphene

#11
20210179939
2021-06-17

Organic ligands for templatable mesoscale nanocapsules

#12
20210171435
2021-06-10

Methods for the treatment of diabetic retinopathy and other ophthalmic diseases

#13
20210077427
2021-03-18

Alkoxy compounds for disease treatment

#14
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#15
20190183816
2019-06-20

Alkoxy compounds for disease treatment

#16
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#17
20190116797
2019-04-25

Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs)

#18
20180346407
2018-12-06

Methods for the treatment of diabetic retinopathy and other ophthalmic diseases

#19
20180272013
2018-09-27

1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof

#20
20180177746
2018-06-28

Alkoxy compounds for disease treatment

#21
20170260126
2017-09-14

SQUALENE COMPOUNDS AS MODULATORS OF LDL-RECEPTOR EXPRESSION

#22
20170066791
2017-03-09

LXR agonists and uses thereof

#23
20170057970
2017-03-02

Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs)

#24
20170049722
2017-02-23

Alkoxy compounds for disease treatment

#25
20160214926
2016-07-28

DIPHENYLOXYALKYLAMINE DERIVATIVES AND ARYLOXYALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITION, USE OF SAID PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING OR INHIBITING CHRONIC PULMONARY INFLAMMATORY DISEASES AND METHOD FOR TREATING OR PREVENTING SUCH DISEASES

#26
20150368187
2015-12-24

Inhibitors of the tumor necrosis factor receptor complex

#27
20150321993
2015-11-12

Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents

#28
20150250793
2015-09-10

BAX agonist, compositions, and methods related thereto

#29
20150239825
2015-08-27

Alkoxy compounds for disease treatment

#30
20150141417
2015-05-21

Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use

#31
20150031688
2015-01-29

Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders

#32
20140371232
2014-12-18

Cajanine structure analogous compound, preparation method and use

#33
20140221384
2014-08-07

Tetra--substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use

#34
20140178374
2014-06-26

BAX agonist, compositions, and methods related thereto

#35
20140039048
2014-02-06

Methods for the treatment of diabetic retinopathy and other ophthalmic diseases

#36
20140031363
2014-01-30

NMDA receptor antagonists for neuroprotection

#37
20130338364
2013-12-19

Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct

#38
20130303531
2013-11-14

Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use

#39
20130289118
2013-10-31

Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use

#40
20130273800
2013-10-17

Structure, synthesis, and applications for oligo phenylene ethynylenes (OPEs)

#41
20130252964
2013-09-26

Compounds and methods for treating candidiasis and aspergillus infections

#42
20130230542
2013-09-05

ROS-activated compounds as selective anti-cancer therapeutics

#43
20130210828
2013-08-15

Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs)

#44
20130197096
2013-08-01

Alkoxy compounds for disease treatment

#45
20130053378
2013-02-28

Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use

#46
20120214852
2012-08-23

Alkoxy compounds for disease treatment

#47
20120149707
2012-06-14

Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same

#48
20120129894
2012-05-24

Alkoxy compounds for disease treatment

#49
20120122938
2012-05-17

Alkoxy compounds for disease treatment

#50
20120095217
2012-04-19

FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF

#51
20110281844
2011-11-17

NON-IMIDAZOLE ALKYLAMINES AS HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS

#52
20110257430
2011-10-20

Cocrystallization

#53
20110257225
2011-10-20

CYCLOHEXYLAMINE DERIVATIVE CONTAINING PHENYL GROUP, AND THERAPEUTIC AGENT FOR DISEASES ACCOMPANIED BY CENTRAL NERVOUS SYSTEM DISORDERS

#54
20110223058
2011-09-15

Structure, synthesis, and applications for oligo phenylene ethynylenes

#55
20110184071
2011-07-28

PROCESS FOR THE PREPARATION OF AMINES

#56
20110105482
2011-05-05

Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders

#57
20110028562
2011-02-03

Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use

#58
20110021577
2011-01-27

Aryloxy amine compounds and their use as sodium channel modulators

#59
20100240634
2010-09-23

Fluorene compound and pharmaceutical use thereof

#60
20100022528
2010-01-28

Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use

#61
20090326074
2009-12-31

Alkoxy compounds for disease treatment

#62
20090306070
2009-12-10

Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use

#63
20090281195
2009-11-12

Cocrystallization

#64
20090253710
2009-10-08

NMDA receptor antagonists for neuroprotection

#65
20090176993
2009-07-09

Calcium receptor active compounds

#66
20090176305
2009-07-09

Compounds and methods for treating breast cancer and other diseases

#67
20090105347
2009-04-23

THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF

#68
20080306036
2008-12-11

Triphenylethylene Compounds Useful as Selective Estrogen Modulators

#69
20080255089
2008-10-16

Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators

#70
20080249177
2008-10-09

Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof

#71
20070276138
2007-11-29

Modulators of peroxisome proliferator activated receptors

#72
20070149608
2007-06-28

3-(4-benzyloxyphenyl) propanoic acid derivatives

#73
20070093556
2007-04-26

Toremifene crystallization method

#74
20070072859
2007-03-29

Pharmaceutical compounds

#75
20060247223
2006-11-02

Non-imidazole alkylamines as histamine H- receptor ligands and their therapeutic applications

#76
20060183918
2006-08-17

β2-adrenergic receptor agonists

#77
20060148893
2006-07-06

Chemical compounds

#78
20060128807
2006-06-15

Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof

#79
20060111352
2006-05-25

Acetylenic compounds useful in treating inflammatory disorders

#80
20060106018
2006-05-18

Acetylenic compounds useful in treating inflammatory disorders

#81
20060035980
2006-02-16

Thyronamine derivatives and analogs and methods of use thereof

#82
20060025474
2006-02-02

Bisphenyl compounds useful as vitamin D3 receptor agonists

#83
20060014779
2006-01-19

3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake

#84
20050277621
2005-12-15

8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents

#85
20050256308
2005-11-17

Spiro compounds, medicinal compositions containing the same and intermediates of the compounds

#86
20050214952
2005-09-29

Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly

#87
20050209275
2005-09-22

β2-adrenergic receptor agonists

#88
20050182081
2005-08-18

Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents

#89
20050113580
2005-05-26

Compounds and methods

#90
20050096485
2005-05-05

Thyronamine derivatives and analogs and methods of use thereof

#91
20050096394
2005-05-05

Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith

#92
20050096384
2005-05-05

Compounds and methods for treating breast cancer and other diseases

#93
20050020838
2005-01-27

Acetylenic compound useful in treating inflammatory disorders

#94
20050020684
2005-01-27

Modulators of peroxisome proliferator activated receptors